Prior exposure to cocaine diminishes behavioral and biochemical responses to aversive conditioning: Reversal by glycine/N-methyl-d-aspartate antagonist co-treatment

[1]  R. Roth,et al.  R-(+)-HA-966, an antagonist for the glycine/NMDA receptor, prevents locomotor sensitization to repeated cocaine exposures , 1995, Brain Research.

[2]  R. Roth,et al.  The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[3]  M. Wolf,et al.  Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization , 1993, Brain Research.

[4]  H. Fibiger,et al.  Enhanced stress-induced dopamine release in the prefrontal cortex of amphetamine-sensitized rats. , 1993, European journal of pharmacology.

[5]  P. Kalivas,et al.  Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex , 1993, Neuroscience.

[6]  Takeshi Inoue,et al.  Effect of conditioned fear stress on serotonin metabolism in the rat brain , 1993, Pharmacology Biochemistry and Behavior.

[7]  P. Piazza,et al.  Repeated corticosterone administration sensitizes the locomotor response to amphetamine , 1992, Brain Research.

[8]  R. Karler,et al.  Excitatory amino acids and the actions of cocaine , 1992, Brain Research.

[9]  P. Wood,et al.  Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents. , 1992, European journal of pharmacology.

[10]  P. Kalivas,et al.  Sensitization to psychostimulants and stress after injection of pertussis toxin into the A10 dopamine region. , 1991, Journal of Pharmacology and Experimental Therapeutics.

[11]  M. Wolf,et al.  Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine , 1991, Brain Research.

[12]  P. Kalivas,et al.  Effects of cocaine and footshock stress on extracellular dopamine levels in the ventral striatum , 1991, Brain Research.

[13]  A. Thomson.  Glycine is a coagonist at the NMDA receptor/channel complex , 1990, Progress in Neurobiology.

[14]  E. Nestler,et al.  Chronic Cocaine Treatment Decreases Levels of the G Protein Subunits Giα and Goα in Discrete Regions of Rat Brain , 1990 .

[15]  P. Duffy,et al.  Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. , 1989, The Journal of pharmacology and experimental therapeutics.

[16]  L. Stinus,et al.  Behavioral sensitization to amphetamine is dependent on corticosteroid receptor activation , 1989, Brain Research.

[17]  P. Kalivas,et al.  Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat , 1989, Biological Psychiatry.

[18]  M W Fischman,et al.  The pharmacology of cocaine related to its abuse. , 1989, Pharmacological reviews.

[19]  F. Bloom,et al.  Cellular and molecular mechanisms of drug dependence. , 1988, Science.

[20]  R. Roth,et al.  Stress and the Mesocorticolimbic Dopamine Systems a , 1988, Annals of the New York Academy of Sciences.

[21]  A. Armario,et al.  Chronic Stress Increases Serotonin and Noradrenaline in Rat Brain and Sensitizes Their Responses to a Further Acute Stress , 1988, Journal of neurochemistry.

[22]  W. Vale,et al.  Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism , 1987, Brain Research.

[23]  T. Robinson,et al.  The effects of footshock stress on regional brain dopamine metabolism and pituitary β-endorphin release in rats previously sensitized to amphetamine , 1987, Neuropharmacology.

[24]  L. Iversen,et al.  Excitatory amino acids in the brain - focus on NMDA receptors , 1987, Trends in Neurosciences.

[25]  A. Lajtha,et al.  Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. , 1986, Biochemical pharmacology.

[26]  T. Robinson,et al.  Sensitization to stress: the enduring effects of prior stress on amphetamine-induced rotational behavior. , 1985, Life sciences.

[27]  R. Roth,et al.  Footshock and conditioned stress increase 3, 4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra , 1985, Brain Research.

[28]  L. Swanson,et al.  The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat , 1982, Brain Research Bulletin.

[29]  E. Ellinwood,et al.  Chronic D-amphetamine in nucleus accumbens: lack of tolerance or reverse tolerance of locomotor activity. , 1981, Life sciences.

[30]  M. Fanselow,et al.  Conditional and unconditional components of post-shock freezing , 1980, The Pavlovian journal of biological science.

[31]  S. Antelman,et al.  Interchangeability of stress and amphetamine in sensitization. , 1980, Science.

[32]  Michael Davis,et al.  Conditioned fear and startle magnitude: effects of different footshock or backshock intensities used in training. , 1978, Journal of experimental psychology. Animal behavior processes.

[33]  R. Wise,et al.  Psychomotor-stimulant sensitization: a unitary phenomenon? , 1993, Behavioural pharmacology.

[34]  P. Kalivas,et al.  The pharmacology and neural circuitry of sensitization to psychostimulants. , 1993, Behavioural pharmacology.

[35]  Michael Davis,et al.  The role of the amygdala in fear and anxiety. , 1992, Annual review of neuroscience.

[36]  M. Le Moal,et al.  Critical role of the hypothalamic pituitary adrenal axis in amphetamine-induced sensitization of behavior. , 1990, Life sciences.

[37]  S. Iversen,et al.  Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Roth,et al.  The determinants of stress-induced activation of the prefrontal cortical dopamine system. , 1990, Progress in brain research.

[39]  I. Creese.  Stimulants, neurochemical, behavioral, and clinical perspectives , 1983 .

[40]  A. Black,et al.  Aversive conditioning and learning , 1971 .